Weight loss is associated with remarkable beneficial outcomes, including improved insulin sensitivity, lower blood pressure, better glycemic control and dyslipidemia, decreased systemic inflammation and endothelial dysfunction, reduced progression of non-alcoholic fatty liver disease (NAFLD), and a lower risk of cardiovascular events and mortality [6]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.